These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 34131572)

  • 1. Modified FOLFIRINOX for unresectable locally advanced or metastatic gallbladder cancer, a comparison with GEMOX regimen.
    Cui XY; Li XC; Cui JJ; Wu XS; Zou L; Song XL; Ren T; Zhu YD; Li HF; Yang Y; Liu K; Han XS; Jia ZY; Wu WG; Wang XA; Gong W; Wang LW; Li ML; Liu YB
    Hepatobiliary Surg Nutr; 2021 Aug; 10(4):498-506. PubMed ID: 34430528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival.
    Kuş T; Aktaş G
    Turk J Urol; 2017 Sep; 43(3):273-278. PubMed ID: 28861297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter Phase II Trial of Gemcitabine Plus Oxaliplatin in Unresectable Gallbladder Cancer.
    Woo SM; Lee SH; Yoo JW; Yang KY; Seo JG; Park JK; Hwang JH; Lee WJ; Ryu JK; Kim YT; Yoon YB
    Gut Liver; 2013 Sep; 7(5):594-8. PubMed ID: 24073318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial.
    Galsky MD; Arija JÁA; Bamias A; Davis ID; De Santis M; Kikuchi E; Garcia-Del-Muro X; De Giorgi U; Mencinger M; Izumi K; Panni S; Gumus M; Özgüroğlu M; Kalebasty AR; Park SH; Alekseev B; Schutz FA; Li JR; Ye D; Vogelzang NJ; Bernhard S; Tayama D; Mariathasan S; Mecke A; Thåström A; Grande E;
    Lancet; 2020 May; 395(10236):1547-1557. PubMed ID: 32416780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of lapatinib and capecitabine in second-line treatment for metastatic pancreatic cancer.
    Wu Z; Gabrielson A; Hwang JJ; Pishvaian MJ; Weiner LM; Zhuang T; Ley L; Marshall JL; He AR
    Cancer Chemother Pharmacol; 2015 Dec; 76(6):1309-14. PubMed ID: 26507197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
    Chiappori AA; Kolevska T; Spigel DR; Hager S; Rarick M; Gadgeel S; Blais N; Von Pawel J; Hart L; Reck M; Bassett E; Burington B; Schiller JH
    Ann Oncol; 2015 Feb; 26(2):354-62. PubMed ID: 25467017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study.
    Sharma A; Dwary AD; Mohanti BK; Deo SV; Pal S; Sreenivas V; Raina V; Shukla NK; Thulkar S; Garg P; Chaudhary SP
    J Clin Oncol; 2010 Oct; 28(30):4581-6. PubMed ID: 20855823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study-CALGB 30607 (Alliance).
    Baggstrom MQ; Socinski MA; Wang XF; Gu L; Stinchcombe TE; Edelman MJ; Baker S; Feliciano J; Novotny P; Hahn O; Crawford JA; Vokes EE
    J Thorac Oncol; 2017 May; 12(5):843-849. PubMed ID: 28161554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary study.
    Liu Y; Yue H; Xu S; Wang F; Ma N; Li K; Qiao L; Wang J
    Int J Clin Oncol; 2015 Oct; 20(5):952-9. PubMed ID: 25712158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy Compared with Best Supportive Care for Metastatic/Unresectable Gallbladder Cancer: a Non-randomized Prospective Cohort Study.
    Singh SK; Talwar R; Kannan N; Tyagi AK; Jaiswal P; Kumar A
    Indian J Surg Oncol; 2016 Mar; 7(1):25-31. PubMed ID: 27065678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].
    Langer F; Helsberg K; Schütte WH; Leschinger MI
    Onkologie; 2005 Mar; 28 Suppl 1():1-28. PubMed ID: 15802886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bevacizumab based chemotherapy is a promising option in metastatic gallbladder adenocarcinoma.
    Aagre SV; Tonse M; Talele A; Sharma S; Advani SH
    Mol Clin Oncol; 2021 Aug; 15(2):153. PubMed ID: 34178324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial resistance in Shigella species: Our five years (2015-2019) experience in a tertiary care center in north India.
    Taneja N; Tiewsoh JBA; Gupta S; Mohan B; Verma R; Shankar P; Narayan C; Yadav VK; Jayashree M; Singh S
    Indian J Med Microbiol; 2021; 39(4):489-494. PubMed ID: 34148675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113.
    Ueno M; Morizane C; Okusaka T; Mizusawa J; Kataoka T; Ikeda M; Ozaka M; Okano N; Sugimori K; Todaka A; Shimizu S; Mizuno N; Yamamoto T; Sano K; Tobimatsu K; Katanuma A; Miyamoto A; Yamaguchi H; Nishina T; Shirakawa H; Kojima Y; Oono T; Kawamoto Y; Furukawa M; Iwai T; Sudo K; Miyakawa H; Yamashita T; Yasuda I; Takahashi H; Kato N; Shioji K; Shimizu K; Nakagohri T; Kamata K; Ishii H; Furuse J;
    Sci Rep; 2021 Jun; 11(1):12885. PubMed ID: 34145336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?
    D'Souza A; Pawar D; Ramaswamy A; Turkar S; Bhargava P; Kapoor A; Mandavkar S; Nashikkar C; Ostwal V
    South Asian J Cancer; 2020 Oct; 9(4):240-244. PubMed ID: 34131576
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Maintenance Gemcitabine in Advanced Carcinoma Gallbladder.
    Sharma M; Talwar V; Maheshwari U; Koyyala VPB; Goel V; Goyal S; Dash PK; Batra U; Bajaj R; Yadav A; Goyal P; Doval DC
    South Asian J Cancer; 2020 Oct; 9(4):204-208. PubMed ID: 34131572
    [No Abstract]   [Full Text] [Related]  

  • 18. Gemcitabine maintenance versus observation after first-line chemotherapy in patients with metastatic urothelial carcinoma: a retrospective study.
    Kim H; Lee SH; Kim DH; Lee JY; Hong SH; Ha US; Kim IH
    Transl Androl Urol; 2020 Oct; 9(5):2113-2121. PubMed ID: 33209674
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.